The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat
- 1 September 2010
- journal article
- Published by Elsevier in Biomaterials
- Vol. 31 (27), 7012-7020
- https://doi.org/10.1016/j.biomaterials.2010.05.078
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The effect of RGD peptides on osseointegration of hydroxyapatite biomaterialsBiomaterials, 2008
- Self‐assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardiumJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2008
- Retention and biodistribution of microspheres injected into ischemic myocardiumJournal of Biomedical Materials Research Part A, 2008
- The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatiteBiomaterials, 2006
- Alginate microspheres prepared by internal gelation: Development and effect on insulin stabilityInternational Journal of Pharmaceutics, 2006
- Review and current status of emulsion/dispersion technology using an internal gelation process for the design of alginate particlesJournal of Microencapsulation, 2006
- Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodelAnnals of Medicine, 2006
- Culture of Neural Stem Cells in Calcium Alginate BeadsBiotechnology Progress, 2006
- In vitro study of alginate?chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failureBiotechnology Letters, 2005
- A model of acute regional myocardial ischemia and reperfusion in the ratMagnetic Resonance in Medicine, 1989